Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities:
Net loss	$ (4,526,641)	$ (4,643,919)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	0	24,447
Stock-based compensation expense	278,131	181,280
Amortization of premium and discount on marketable securities	(13,546)	0
Changes in operating assets and liabilities:
Prepaid expenses, deposits and other assets	(495,903)	(417,677)
Accounts payable, accrued expenses and other liabilities	28,146	(320,501)
Net cash used in operating activities	(4,729,813)	(5,176,370)
Cash flows used in investing activities:
Purchases of marketable securities	(22,716,415)	0
Net cash used in investing activities	(22,716,415)	0
Proceeds from the sale of common stock, net of issuance costs	0	31,094,302
Proceeds received from the exercise of common stock warrants	0	2,201,450
Proceeds from the sale of series C preferred stock to related parties	5,000	0
Net cash provided by financing activities	5,000	33,295,752
Net (decrease) increase in cash and cash equivalents	(27,441,228)	28,119,382
Cash and cash equivalents at beginning of year	37,313,558	18,515,595
Cash and cash equivalents at end of period	9,872,330	46,634,977
Supplemental disclosure of non-cash activities:
Unrealized loss on marketable securities	$ 49,658	$ 0